Past PRESENTERS

2007 - 2018


2018

Sara Lappan, Ph.D.
Postdoctoral Fellow, Adjunct Professor, School of Public Health, University of Alabama
"Psilocybin-facilitated Treatment for Cocaine Use"

Benjamin De Loenen
Founder and Executive Director, International Center for Ethnobotanical Education Research & Service
“The Inner Search For A Better World: The Challenging Journey of Integrating Psychoactive Plant Practices Into Contemporary Society”

Annie Oak
Event Producer, Human Rights and Risk Reduction Activist
“Building Risk Reduction and Community Safety Systems in Festival Environments"

Michael Pollan
American Author, Journalist, and Activist, Professor of Journalism, UC Berkeley Graduate School of Journalism
“How to Change Your Mind : What the New Science of Psychedelics Teaches Us about Consciousness, Dying, Addiction, Depression, and Transcendence”

Jae Sevelius, Ph.D.
Associate Professor Division of Prevention Sciences Center of Excellence for Transgender Health, Department of Medicine at the University of California, San Francisco
"Psychedelic Justice: Exploring the Intersections of Healing, Liberation, and Social Change"

Christopher Timmermann, Ph.D. (cand)
Ph.D. candidate, Psychedelic Research Group, Department of Medicine, Imperial College, London
“Dynamics of Brain Activity and Conscious Experience Induced By DMT”

Bett Williams
Author, Journalist, and Radio Host for Planet Juniper
“The Wild Kindness; Between Sacred and Secular in the New Mushroom Underground”

Monnica Williams, Ph.D.
Associate Professor in the Department of Psychological Sciences at the University of Connecticut, Director of the Laboratory for Culture and Mental Health Disparities, Clinical Director of the Behavioral Wellness Clinic, LLC, Mansfield, Connecticut, Board-Certified, Licensed Clinical Psychologist
“Race-Based Trauma: The Challenge and Promise of MDMA-Assisted Psychotherapy”

Dustin Yellin
Founder and Director, Pioneer Works
“How Heavy is a Light Year"

Dráulio Barros de Araújo, Ph.D.
Professor of Neuroscience, Brain Institute, Federal University of Rio Grande do Norte, Brazil
“New Findings on the Therapeutic Potential of Ayahuasca”

Dawn D. Davis, Ph.D. (cand)
PNW-COSMOS/AGEP Scholar, NSF-ISTEM Scholar, and NSF-IGERT Associate, Indigenous Researcher
“Peyote Habitat Loss: An Examination of Threats Using GIS”

Evgenia Fotiou, Ph.D.
Cultural Anthropologist, Kent State University
“Reflecting on the Globalization of Ayahuasca”

Ingmar Gorman, Ph.D.
Co-Clinical Investigator, MAPS MDMA-Assisted Psychotherapy Study,  NYU Rory Meyers College of Nursing Director, Psychedelic Education and Continuing Care Program Board Member, Horizons Media, Inc.
"MDMA-Assisted Clinical Study of PTSD: Update and Therapists' Experience"

Willa Hall, Ph.D.
Clinical Psychologist, Sub Investigator and Therapist
"MDMA-Assisted Clinical Study of PTSD: Update and Therapists' Experience"

Peter Hendricks, Ph.D.
Clinical psychologist, Professor of Clinical Psychology, University of Alabama
"Psilocybin-facilitated Treatment for Cocaine Use"

Julie Holland, M.D.
Psychiatrist, Pharmacologist, Author
Saturday Science & Medicine Host & Moderator

Sophia Korb, Ph.D.
Clinical Psychologist
“Microdosing: The Phenomenon, Research Results, and Startling Surprises”

Beatriz Caiuby Labate, Ph.D.
Visiting Professor, Center for Research and Post Graduate Studies in Social Anthropology (CIESAS) in Guadalajara Adjunct Faculty, East-West Psychology Program at the California Institute of Integral Studies (CIIS) in San Francisco, Co-founder, Interdisciplinary Group for Psychoactive Studies (NEIP), Brazil, Co-founder of the Drug, Politics, and Culture Collective, Mexico, Chief Editor, Chacruna
Sunday Culture & Philosophy Host & Moderator


2017

Michael P. Bogenschutz, M.D.
Research Professor of Psychiatry at NYU Langone Medical Center
“A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence”

Thomas Kingsley Brown, Ph.D.
Researcher at Multidisciplinary Association for Psychedelic Studies (MAPS), Coordinator of McNair Scholars Program at UC San Diego
“The Past, Present, and Future of Ibogaine Treatment – and Why it Matters for the Opioid Crisis”

Shannon Clare Carlin, M.A. IMF
MAPS Public Benefit Corporation (MPBC) Therapy, Training Program Manager, Zendo Project Integration Coordinator, Co-therapist in MAPS-Sponsored Clinical Trials
“Vision Becomes Reality: the Making of a Legal MDMA Therapist Through Recent Research”

Neşe Devenot, Ph.D.
Andrew W. Mellon Postdoctoral Fellow in Digital, Humanities, University of Puget Sound
“The Role of Poetic Language in Psychedelic Science”

Holly Duane
Therapist, NYU School of Medicine
“A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence”

Amanda Feilding
Founder and Director of the Beckley Foundation
“From the Mystical Experience to Microdosing”

Débora González, Ph.D.
Clinical Psychologist and Pharmacologist with ICEERS Foundation
“The Therapeutic Potential of Altered States of Consciousness in Grieving Processes”

Rob Heffernan
Ayahuasca Defense Fund Associate, Independent Researcher, Activist
“Guard-en-ing the Gates of Heaven: Protecting and Cultivating the Legality, Health and Safety of Sacred Medicines”

Mendel Kaelen, Ph.D.
Postdoctoral Research Associate, Imperial College London
“Music in Psychedelic Therapy”

Anja Loizaga-Velder
Ph.D.Postdoctoral Research Associate, School of Medicine, National Autonomous University of Mexico
“New Psychotherapeutic Perspectives With Ancient Medicines”

Elizabeth M. Nielson, Ph.D.
Psychologist, Department of Psychiatry, NYU Langone Medical Center
“What Psychedelic Therapists Don’t Talk About and Why: The Case for Research on First-hand Experience with Psychedelics”

Nicholas Byron Powers, Ph.D.
Poet, Journalist, Associate Professor of English, SUNY Old Westbury
“Black Masks, Rainbow Bodies: Race and Psychedelics”

Stacy B. Schaefer, Ph.D.
Professor Emerita in the Department of Anthropology, California State University, Chico (CSUC), Former Co-Director of the Museum of Anthropology (CSUC)
“Communing with the Gods: Peyote (Lophophora williamsii) in the Lifecycle of Huichol Indians of Mexico”

Philip E. Wolfson, M.D.
Psychiatrist, Psychotherapist, and Principal Investigator, MAPS
“Ketamine Assisted Psychotherapy and the Ketamine Opportunity”


2016

Alicia Danforth, Ph.D.
Researcher, Los Angeles Biomedical Research Institute Harbor-UCLA Medical Center
“Exploring MDMA-Assisted Therapy as a Social Adaptability Catalyst for Autistic Adults”

Bia Labate, Ph.D.
Visiting Professor at the Center for Research and Post Graduate Studies in Social Anthropology (CIESAS), Guadalajara, Mexico
“The Field of Ayahuasca Research: A Retrospective”

Ellen Spiro
Professor of Radio-TV-Film, University of Texas, Documentary Filmmaker
“The Field of Ayahuasca Research: A Retrospective”

Fred Tomaselli
American Artist
“My Chemical Sublime”

Ingmar Gorman, M.A.
Doctoral Student, New School for Social Research, Department of Psychology, The New School for Social Research
“Psychedelic Integration: From the Individual to the Community”

Jag Davies
Director of Communications Strategy, Drug Policy Alliance
“Envisioning Success: What Does the End of Psychedelic Criminalization Really Look Like?”

Jesse Jarnow
Author, Heads: A Biography of Psychedelic America
“An Alternate and Ongoing History of Psychedelics”

Jessica L. Nielson, Ph.D.
Assistant Professional Researcher, Department of Neurosurgery, Brain and Spinal Injury Center (BASIC) University of California, San Francisco
“Ayahuasca for PTSD: Assessing Benefits and Risks from Multiple Perspectives”

Katherine MacLean, Ph.D.
Director, Psychedelic Education and Continuing Care Program, Center for Optimal Living
“Psychedelic Integration: From the Individual to the Community”

Kenneth Tupper, Ph.D.
Adjunct Professor, School of Population and Public Health, University of British Columbia
“Beyond Healing: Psychedelics as Cognitive Tools for Learning”

Michael Mithoefer, M.D.
Lead Clinical Investigator and Medical Monitor, MDMA- Assisted Psychotherapy for PTSD
“MDMA-Assisted Psychotherapy Research – An Update on Twelve Years of Successful Clinical Trials”

Natalie Lyla Ginsberg
MAPS Policy and Advocacy Manager
“Rescheduling MDMA: History, Present, and Future”

Rick Doblin, Ph.D.
Founder and Executive Director, MAPS
“Rescheduling MDMA: History, Present, and Future”

Robert Jesse
Convenor of the Council on Spiritual Practices
“Psychedelics: The Uncertain Paths from Re-emergence to Renaissance”

Roland Griffiths, Ph.D.
Professor in the Departments of Psychiatry and Neurosciences, Johns Hopkins University School of Medicine
“The Johns Hopkins Psilocybin Research Project: Overview, Phenomenology, and Therapeutic Applications”

Samantha Podrebarac, MSc
Clinical Research Coordinator, Department of Psychiatry, NYU Langone School of Medicine, Masters student, Spirituality Mind-Body Institute, Teachers College, Columbia University
“The NYU Psilocybin Project: Neuroimaging & Spiritual Health”

Sarah Mennenga, Ph.D.
Postdoctoral Fellow, Department of Psychiatry, NYU Langone School of Medicine
“The NYU Psilocybin Project: Insights from Basic Neuroscience”

Stephen Ross, M.D.
Associate Professor of Psychiatry, Child & Adolescent, Psychiatry, and Oral & Maxillofacial Pathology, Radiology and Medicine Director, Division of Alcoholism & Drug Abuse, Department of Psychiatry, Bellevue Hospital Director, Bellevue Hospital Opioid Overdose Prevention Program Director, Addiction Psychiatry, NYU Tisch Hospital Director, NYU Addiction Psychiatry Fellowship Director, NYU Psychedelic Research Group, Principal Investigator, NYU Psilocybin Cancer Project, NYU Langone Medical Center, NYU School of Medicine, NYU College of Dentistry, NYU-HHC Clinical & Translational Science Institute
“NYU Psychedelic Research Group: Past, Present, Future”


2015

Charlotte Walsh, LLB, MPhil
Lecturer, School of Law, University of Leicester and member of the ICEERS Expert Committee for the Regularization of Psychoactives
“Psychedelic Drug Policy Activism: Why Cognitive Liberty Matters”

Daniel Pinchbeck
Author, Co-founder of evolver.net and Reality Sandwich
“Psychedelics and Deep Ecology”

Draulio Barros de Araujo, Ph.D.
Professor of Neuroimaging, Brain Institute, Natal, Brazil
“Ayahuasca, Awareness and Depression”

Frederick Barrett, Ph.D.
Faculty Member in Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine
“Psilocybin, Meditation, Mystical Experiences, and the Brain”

Gabrielle Agin-Liebes
Co-Investigator, NYU Qualitative Interview Study
“Reuniting with Oneself in the Face of Cancer: the Lived Experiences of Participants in the NYU Cancer Anxiety Study”

Jeffrey Guss, M.D.
Clinical Assistant Professor of Psychiatry and Child and Adolescent Psychiatry at New York University School of Medicine
“The Voices of the NYU Psilocybin Cancer Anxiety Project”

Jonathan Thompson
Founder and “Chief Operating Dad” of PsychedelicParenting.org
“Reclaiming Religious Freedom and Family Values: A Conversation on Psychedelic Parenting”

Michael P. Bogenschutz, M.D.
Professor of Psychiatry, NYU School of Medicine
“Psychedelic-assisted Treatment of Addiction: Current Work with Psilocybin in the Treatment of Alcoholism”

Neal M. Goldsmith, Ph.D.
Psychotherapist and Author, Psychedelic Healing: The Promise of Entheogens for Psychotherapy and Spiritual Development
“Psychedelics and Death: A Brief Introduction”

Patrick Murphy, B.F.A.
Film & Television, New York University Tisch School of the Arts, Casa Vera Productions
“The Voices of the NYU Psilocybin Cancer Anxiety Project”

Rick Doblin, Ph.D.
MAPS Founder and Executive Director
“FDA Approval of MDMA-assisted Psychotherapy: On the Horizon”

Robin Carhart-Harris, MA, Ph.D.
Post-doctoral Research Associate, Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London
“Psychedelic Brain Imaging and Depression”

Stefanie Jones
Nightlife Community Engagement Manager, Drug Policy Alliance
“Psychedelics, Partying, and Policy”

Stephen Ross, M.D.
Associate Professor of Psychiatry and Child & Adolescent Psychiatry at New York University School of Medicine
“The Voices of the NYU Psilocybin Cancer Anxiety Project”


2014

Alexander Belser
Co-Founder of the New York University Psilocybin Cancer Anxiety Study
“Toward a New Understanding of Altered States of Consciousness: Egolysis and Egolytic States”

Amber Lyon
Emmy Award-winning Investigative Journalist, Author, Filmmaker, and Former CNN Correspondent
“How Psychedelics Transformed My Life”

Annie Lalla
Relationship Coach, Honors Bachelor of Science in Biology & Philosophy
“Leading My Family To Ecstasy”

Casey A. Paleos, M.D.
Co-Principal Investigator of the NYU-Bellevue IV Ketamine for Depression Study
“Toward a New Understanding of Altered States of Consciousness: Egolysis and Egolytic States”

Clancy Cavnar, Psy.D.
Registered Psychologist, NEIP
“The Effect of Participation in Ayahuasca Rituals on Gay and Lesbian Self- Perception”

Graham Hancock
Author and Philosopher
“Psychedelics and Civilization, Light and Darkness”

Hamilton Morris
Journalist and Science Editor of Vice Magazine, Contributor to Harper’s Magazine
“Journalistic Responsibility in the Coverage of Psychedelics”

Jeffrey Guss, M.D.
Co-Investigator in the NYU Psilocybin Cancer Anxiety Study
“Toward a New Understanding of Altered States of Consciousness: Egolysis and Egolytic States”

John Harrison, Psy.D.
Founder-Director, Addiction Treatment Specialists
“Realizing Transformation: Integration and Continuing Care in the Psychedelic Treatment of Addiction”

Katherine MacLean, Ph.D.
Research Scientist and Meditation Practitioner
“Psilocybin and Personality Change: Opening to Life, Death, and Everything In Between”

Nicholas Blackston
Former Marine, Participant in the MAPS Clinical Trial of MDMA-Assisted Psychotherapy for PTSD
“Acid Test: LSD, Ecstasy and the Power to Heal”

Peter Gasser, M.D.
Psychiatrist and Psychotherapist
“Does LSD Have a Future in Medicine?”

Peter H. Addy, Ph.D.
Postdoctoral Associate, Psychiatry, Yale University School of Medicine
“Salvia Divinorum, an Atypical Psychedelic”

Tom Shroder
Author and Former Editor of The Washington Post Magazine
“Acid Test: LSD, Ecstasy and the Power to Heal”


2013 speakers

Albert Garcia-Romeu, Ph.D.
Postdoctoral Fellow at Johns Hopkins University School of Medicine
“Psilocybin in the Treatment of Smoking Addiction: An Update from the Johns Hopkins Research Team”

Anthony Bossis, Ph.D.
Clinical Assistant Professor of Psychiatry at New York University School of Medicine, Clinical Researcher at the NYU Bluestone Center For Clinical Research
“Acid Test: LSD, Ecstasy and the Power to Heal”

Dennis J. McKenna, Ph.D.
Assistant Professor, Center for Spirituality and Healing at University of Minnesota, Director of Ethnopharmacology, Heffter Research Institute
“Ayahuasca Yesterday Today and Tomorrow: Perspectives on the Past & Future of Ayahuasca”

Diana Slattery, Ph.D.
Poetry and Fiction Writer, Author of “Bizarre Births”
“The Psychedelic Origins of Language”

Earth Erowid
Technical Director, Erowid Center
“State of the Stone 2013: A Rapidly Changing Landscape”

Fire Erowid
Executive Director, Erowid Center
“State of the Stone 2013: A Rapidly Changing Landscape”

Linnae Ponté
Executive and Clinical Research Assistant, Harm Reduction Coordinator, MAPS
“MAPS Harm Reduction and Research Update”

Marcela Ot’alora, Ph.D.
Installation Artist, Psychotherapist, and Principal Investigator of MAPS’ Phase 2 MDMA-Assisted Psychotherapy Study
“Treating PTSD with MDMA-assisted Psychotherapy”

Rachel Harris, Ph.D.
Psychologist and Author of "20-Minute Retreats"
“Ayahuasca Use in North America”

Thomas B. Roberts, Ph.D.
Professor Emeritus of Educational Psychology in the Department of Leadership, Educational Psychology and Foundations at Northern Illinois University
“The Psychedelic Future of the Mind: Enabling Consilience, Enhancing Cognition, and Enriching the Humanities”

Yalila Espinoza, Ph.D.
Sexual and Spiritual Counselor, 13 Moon Initiation Facilitator
“The Light & Shadow of Sexuality in Shamanism”


2012

Alexander Belser
Fellow in the Department of Applied Psychology at New York University
“The Rule of Three from NYU: 1. A Patient Speaks, 2. A Proposed Narrative Study of Patient Experiences, and 3. Recent Findings from NYU Psilocybin Cancer Anxiety Society”

Amy Emerson
Director of Clinical Research, MAPS
“MDMA Assisted Psychotherapy for PTSD Research: Bridging Biology and Psychology”

Charles S. Grob, M.D.
Professor of Psychiatry and Pediatrics at the UCLA School of Medicine, Director of the Division of Child and Adolescent Psychiatry at the Harbor-UCLA Medical Center
“Why Psychedelics Matter”

James Kent
Software Engineer, Writer
“Psychedelic Information Theory: Mapping the Limits of Human Perception and Imagination”

Kevin Feeney, J.D.
Co-Author of "Medical Marijuana Law"
“Ayahuasca & Law: International Perspective”

Mariavittoria Mangini, Ph.D., FNP
Founder of the Women’s Visionary Council
“Gender and Psychedelics: Exploring the Woman’s Experience”

Matthew Baggott, Ph.D.
Neuroscientist
“Beyond Fear: The Effects of MDMA in Humans”

Ralph Metzner, Ph.D.
Psychotherapist, Author, Psychedelic Pioneer, Philosopher, Professor Emeritus at California Institute of Integral Studies
“Psychoactive Substances in Shamanism and Psychotherapy”

Roman Hanis
Director of the Paititi Institute in Iquitos, Peru
“Amazonion Grass Roots Research on Entheogen-based Healing of Physical Pathologies”

Sidarta Ribeiro, Ph.D.
Neuroscience Professor and Director, Brain Institute, Federal University of Rio Grande do Norte, Brazil
“Seeing with Eyes Shut: Neural Basis of Enhanced Visual Imagery Following Ayahuasca Ingestion”


2011

Berra Yazar-Klosinski, Ph.D.
Research Associate with Geron Corporation on Telomerase Activation
“MAPS’ International Psychedelic Clinical Research: The Past, Present, and Future”

Biatriz Caiuby Labate, Ph.D.
Research Associate at the Institute of Medical Psychology, Heidelberg University, Member of the Collaborative Research Center
“Ayahuasca in a Global Context: Controversies, Public Debate, and Regulation”

Jim Fadiman, Ph.D.
Co-founder and Teacher, Institute for Transpersonal Psychology
“New Frontiers In Psychedelic Research: Letting Go of the Medical Model”

Juan R. Sanchez-Ramos, M.D., Ph.D.
Director of the HDSA Center of Excellence at USF
“Effects of Psilocybin and other Selective Serotonin Agonists on Hippocampal Neurogenesis”

Ken Johnson
Independent Writer and Critic
“Art Under the Influence: 1965 to Now”

Matthew W. Johnson, Ph.D.
NIH-Funded Psychopharmacologist
“Recent Findings from the Johns Hopkins Hallucinogen Research Group”

Nicolas Langlitz, Ph.D.
Assistant Professor at the Department of Anthropology of the New School for Social Research in New York
“Lullaby for a Mouse: Anthropological Observations of an Animal Model of Psychosis”

Roy S. Haber, LL.B.
Attorney
“Legal Issues Regarding the Santo Daime Church”

Stephan Beyer, Ph.D.
Scholar, Adventurer, and Expert on Jungle Survival and Plant Hallucinogens
“Ayahuasca, Cognitive Psychology, and the Ontology of Hallucination”


2010

Annie Oak
Journalist and Businesswoman
“Women Who Work with Psychedelics: Healers, Artists, Rangers, and Priestesses”

Clare S. Wilkins
Director of Pangea Biomedics, Tijuana, Mexico
“Four-Hundred Ibogaine Sessions: Data on Detoxification, Recidivism, and Quality of Life”

Dale Pendell
Poet, Author
“Psychedelics, Deep Ecology, and the Matter of Entities”

Don Lattin
Freelance Journalist and Author
“Reading from, The Harvard Psychedelic Club”

Erik Davis
Writer and Speaker
“Psychedelics: Between Natural and Supernatural”

Jeffrey Guss, M.D.
Clinical Assistant Professor of Psychiatry at the New York University School of Medicine
“The NYU Training Program in Psychedelic Psychotherapy for Cancer Related Anxiety”

John Perry Barlow
American Poet, Essayist, Activist
“Reading from, The Birth of a Psychedelic Culture”

JP Harpignies
Associate Producer of Annual Bioneers Eco Conference
“Psychedelics, Utopianism and Psycho-Spiritual Inflation”

Mary P. Cosimano, MSW
Research Coordinator and Study Session Guide in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine
“Electroacoustic Cello Performance”

Matthew W Johnson, Ph.D.
Assistant Professor of Psychiatry in the Department of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine
“Psilocybin in Smoking Cessation: A Pilot Study”

Neal M. Goldsmith, Ph.D.
Therapist, Author, Public Speaker
“Psychedelics, Psychotherapy, and Change”

Rick Strassman, M.D.
President and Co-Founder of the Cottonwood Research Foundation, and Clinical Associate Professor of Psychiatry, University of New Mexico
“Old Testament Prophecy: A Western Model of the Psychedelic Experience”

Torsten Passie, M.D.
Assistant Professor for Consciousness Studies, Hannover Medical School, Germany
“The History and Special Sociology of Psychedelic Studies”


2009

Alicia Danforth
Clinical Psychedelic Researcher
“Little Pieces of a Big Dream: Participants’ Stories from a Cancer Anxiety Study with Psilocybin”

Andy Letcher
Freelance Writer, Academic Lecturer, Folk Musician
“Reading the Codex: Making Sense of Mushrooms”

Bob Jesse
Organizer of the Council on Spiritual Practices
“Entheogens, Awakening, and Spiritual Development”

Bob Wold
Founder and President of Clusterbusters, Inc.
“Suicide or Psychedelics”

Earth Erowid
Technical Director, Erowid Center
“Connecting the Microdots: State of the Stone 2009”

Fire Erowid
Executive Director, Erowid Center
“Connecting the Microdots: State of the Stone 2009”

Franz X. Vollenweider, M.D.
Director of the Psychopharmacology and Brain Imaging Research Unit, University Hospital of Psychiatry
“Neuronal Network and Neurotransmitter Dynamics Underlying Psychedelic-Induced Altered States of Consciousness in Humans”

Stephen Ross, M.D.
Principal Investigator of the new Psilocybin Cancer Project at NYU
“The NYU Psilocybin Cancer Project”

Valerie Mojeiko
Psychologist and Integral Theorist
“Psychedelic Harm Reduction--Rethinking the 'Bad Trip'”

William Richards, Ph.D.
Psychologist, Psychiatry Department, Johns Hopkins University School of Medicine
“The Rebirth Of Research With Entheogens: Lessons From The Past And Hypotheses For The Future”


2008

Alex & Allyson Grey
Author, Teacher and Writer
“Psychedelic Families: What Do We Tell the Children?”

Alex Grey
Artist, Co-Founder of the Chapel of Sacred Mirrors (CoSM)
“Contemporary Visionary Culture”

Alexander “Sasha” Shulgin, Ph.D.
Pharmacologist, Chemist, Drug Developer
“Q&A format on Psychedelic Chemistry, History, Policy, the Future”

Allan Hunt Badiner
Writer, Activist
“Catching the Buzz: Drugs or Dharma?”

Ann Shulgin
Lay-Therapist with Psychedelic Substances
“Q&A format on Psychedelic Chemistry, History, Policy, the Future”

Bob Wold
Founder and President of Clusterbusters, Inc.
“Cluster Headaches and Psilocybin: A New Medication on the Horizon”

Dan Merkur
Author
“The Social Location of Psychedelic Mysticism”

Daniel Pinchbeck
Author, Journalist, Philosopher, Founder of Open City
“The Future of Psychedelics”

David E. Nichols, Ph.D.
Professor of Medicinal Chemistry and Pharmacology in the School of Pharmacy and Pharmaceutical Sciences at Purdue University, Co-founder of the Heffter Institute
“Is There a Renaissance in Psychedelic Research and How did it Happen?”

Dimitri Mobengo Mugianis
Founding Member of Freedom Root, The Ibogaine Project
“Ibogaine Healing in America and Gabon: A Contrast in World View and Public Policy”

Rick Doblin, Ph.D.
Founder and Executive Director, MAPS
“Mainstreaming Psychedelic Medicine: Patience is the Fastest Way”

Robert Forte
Editor of Entheogens and the Future of Religion
“Psychedelic Drugs and the Religious Experience: The Politics of Methodology”

Roland Griffiths, Ph.D.
Professor in the Departments of Psychiatry and Neurosciences at the Johns Hopkins University School of Medicine
“Psilocybin Occasions Mystical-Type Experiences Having Sustained Personal Meaning and Spiritual Significance”


2007

Alex Grey
Artist, Co-Founder of the Chapel of Sacred Mirrors (CoSM)
“Creativity, Spirituality and Psychedelics”

Allyson Grey
Author, Teacher and Writer
“Creativity, Spirituality and Psychedelics”

Andrew Sewell, M.D.
Attending Physician, VA Connecticut Healthcare
“Clusterbusting with LSA”

Charles Grob, M.D.
Director of the Division of Child and Adolescent Psychiatry at Harbor- UCLA Medical Center, Professor of Psychiatry and Pediatrics at the UCLA School of Medicine
“Psilocybin Mushroom Research”

Ethan Nadelmann, Ph.D.
Founder and Executive Director of the Drug Policy Alliance
“Psychedelics and Drug Reform”

Julie Holland, M.D.
Forensic Consultant
“The History of MDMA and Therapy”

Kenneth Alper, M.D.
Associate Professor in the Departments of Psychiatry and Neurology, New York University School of Medicine
“Ibogaine and Addiction”

Michael Mithoefer, M.D.
Psychiatrist, Clinical Assistant Professor of Psychiatry, The Medical University of South Carolina
“MDMA Facilitated Treatment of PTSD”

Neal M. Goldsmith, Ph.D.
Therapist, Author, Public Speaker
“The Ten Lessons of Psychedelic Psychotherapy, Rediscovered”

Rick Doblin, Ph.D.
Founder and Executive Director, MAPS
“The Psychedelic Renaissance”